Search

everythinglearnresearchcommunity

for

Search:↓

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

CEC levels may be a useful marker for predicting prostate cancer progression.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.